O
OppenheimerFunds’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $16.3M | Buy |
183,254
+7,735
| +4% | +$687K | 0.02% | 583 |
|
2018
Q4 | $14.9M | Sell |
175,519
-2,612
| -1% | -$222K | 0.02% | 579 |
|
2018
Q3 | $17.3M | Hold |
178,131
| – | – | 0.02% | 621 |
|
2018
Q2 | $16.8M | Sell |
178,131
-1,083,831
| -86% | -$102M | 0.02% | 625 |
|
2018
Q1 | $102M | Sell |
1,261,962
-55,172
| -4% | -$4.47M | 0.13% | 175 |
|
2017
Q4 | $117M | Sell |
1,317,134
-31,239
| -2% | -$2.79M | 0.14% | 165 |
|
2017
Q3 | $125M | Sell |
1,348,373
-239,577
| -15% | -$22.3M | 0.15% | 155 |
|
2017
Q2 | $144M | Sell |
1,587,950
-81,407
| -5% | -$7.39M | 0.18% | 144 |
|
2017
Q1 | $147M | Sell |
1,669,357
-10,020
| -0.6% | -$880K | 0.18% | 148 |
|
2016
Q4 | $139M | Sell |
1,679,377
-484,776
| -22% | -$40.2M | 0.18% | 145 |
|
2016
Q3 | $200M | Buy |
2,164,153
+95,140
| +5% | +$8.8M | 0.25% | 111 |
|
2016
Q2 | $161M | Buy |
2,069,013
+201,629
| +11% | +$15.7M | 0.21% | 127 |
|
2016
Q1 | $154M | Buy |
1,867,384
+152,696
| +9% | +$12.6M | 0.2% | 126 |
|
2015
Q4 | $180M | Sell |
1,714,688
-120,150
| -7% | -$12.6M | 0.23% | 109 |
|
2015
Q3 | $193M | Sell |
1,834,838
-78,910
| -4% | -$8.31M | 0.26% | 101 |
|
2015
Q2 | $262M | Sell |
1,913,748
-4,190
| -0.2% | -$573K | 0.3% | 88 |
|
2015
Q1 | $239M | Buy |
1,917,938
+150,530
| +9% | +$18.8M | 0.27% | 107 |
|
2014
Q4 | $160M | Sell |
1,767,408
-62,440
| -3% | -$5.64M | 0.18% | 155 |
|
2014
Q3 | $132M | Buy |
1,829,848
+1,345,578
| +278% | +$97.1M | 0.15% | 179 |
|
2014
Q2 | $30.1M | Sell |
484,270
-29,070
| -6% | -$1.81M | 0.03% | 475 |
|
2014
Q1 | $35M | Buy |
513,340
+245,040
| +91% | +$16.7M | 0.04% | 428 |
|
2013
Q4 | $18.9M | Buy |
268,300
+175,630
| +190% | +$12.3M | 0.02% | 575 |
|
2013
Q3 | $6.69M | Sell |
92,670
-130
| -0.1% | -$9.39K | 0.01% | 779 |
|
2013
Q2 | $5.18M | Buy |
+92,800
| New | +$5.18M | 0.01% | 783 |
|